Reimagine what’s possible at the point of care
Atellica DCA Analyzer
Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.
Compact. Portable. Scalable. Customizable.
Building upon one of the industry’s most trusted technologies for diabetes testing, the Atellica DCA Analyzer puts fast, quality HbA1c and ACR results right at your fingertips. Experience the performance and precision you need to improve outcomes. Designed with the speed, standardization, and personalization you want to boost efficiencies and meet growing demand.
Scalable and Connected
Connect and operate up to three test modules with a single display and transmit results with secure BLUETOOTH, Wireless or Wired connections for seamless data transmission to LIS/HIS/EHR systems.
Flexible Workflow
With a unique handheld, detachable display users can link patient IDs and access results from wherever they are needed. Multiple modules and test types (i.e., HbA1c and ACR) can be run simultaneously.
Compact and Portable
Small footprint and light weight with a built-in handle enables easy movement for storage or bringing directly to patient.
Rapid Results
HbA1c results available in only 4 minutes can help ensure timely patient consultation and treatment paths. ACR results in only 7 minutes can help aid in the early diagnosis of kidney disease.
Positive Patient Experience
Small sample size, sufficient sample hold time, and the ability to process hemolyzed samples mitigate pre-analytical errors and reduce patient discomfort from re-sticks.
Enhanced Patient Conversations
Built-in patient trend graphs to complement patient consultations and aid clinical decision-making.
HbA1c results available in 4 minutes, ACR results available in 7 minutes.
Trusted Performance
- Lab-quality results using technology with 30+ years of proven clinical reliability.
- Atellica DCA Analyzer strongly correlated to results from the Tosoh G8 laboratory method.1
- No clinically significant interferences from common hemoglobin variants for HbA1c measurements.2
- Atellica DCA HbA1c test is not affected by hemolyzed samples and can help reduce preanalytical errors.
Built-in Safeguards
Auto-Checks™ Technology ensures accurate sample processing and reliable results, and built-in risk mitigation features provide an audit-ready solution.
Security measures protect patient data.
- No patient data transmitted between display and module.
- Operator access control prevents unauthorized access.
- Operator lockout after five failed attempts.
- TLS encryption protects from cybersecurity threats.
- USB debugging port is disabled.
- Manually exported data is password protected.
Intuitive User Interface
Simple operation and intuitive UI decreases likelihood of operator error, improves user experience, and reduces training complexity.
Leading the way in POC diabetes testing for more than 30 years.
The Atellica DCA Analyzer uses the same robust latex agglutination inhibition immunoassay as the DCA Vantage and DCA 2000+ analyzers.
Building upon one of the industry’s most trusted technologies for diabetes testing, our HbA1c immunoassay chemistry delivers reliable results, test after test.
Only 1μL capillary or venous whole blood
Small sample size reduces patient discomfort and likelihood of operator error.
Heparinized capillary
Enables extended sample hold time, mitigates risk of lost samples and need to retest patients.
Unaffected by sample hemolysis
Atellica® DCA HbA1c test can process hemolyzed samples and helps reduce pre-analytical errors caused by specimen collection.
Specificity to HbA1c can achieved with immunoassay
Unlike other methodologies, Siemens Healthineers immunoassay test was specifically designed to target only HbA1c.
Don't miss these events
Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.